Related Experiment Video
Updated: Jun 7, 2025

Using Unidirectional Rotations to Improve Vestibular System Asymmetry in Patients with Vestibular Dysfunction
Published on: August 30, 2019
Vestibular Paroxysmia: A Four-Case Report
Elizabeth G Saenz Zapata1, Monica P Alcantara Thome1, Blanca Isabel Perez Hernandez2
1Audiology and Otoneurology, Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City, MEX.
Vestibular paroxysmia (VP), a rare neurovascular disorder, causes vertigo due to vestibulocochlear nerve compression. Effective treatment with oxcarbazepine was observed in four patients, highlighting its diagnostic and therapeutic value.
Area of Science:
- Neurology
- Otolaryngology
Background:
- Vestibular paroxysmia (VP) is a rare neurovascular compression disorder affecting the vestibulocochlear nerve.
- It is characterized by demyelination resulting from vascular loop compression and ephaptic transmission.
Observation:
- Four patients over 40 with recurrent vertigo, unresponsive to prior treatments, were studied.
- Symptoms included spontaneous or head-movement-triggered vertigo episodes.
- MRI revealed neurovascular compression of the VIII cranial nerve in all patients.
Findings:
- Oxcarbazepine treatment led to a positive response in all four patients.
- This suggests a strong therapeutic effect of oxcarbazepine in VP.
- The study reinforces the diagnostic criteria and treatment response for VP.
Implications:
- VP diagnosis can be challenging due to its rarity.
- A trial of medication, specifically oxcarbazepine, should be considered for suspected VP cases.
- This approach can aid in diagnosing and managing this vestibular syndrome effectively.
More Related Videos
Related Concept Videos
Equilibrium and Balance
Hyperpnea and Hyperventilation
Pathophysiology of Vomiting

